Category: Consumer goods
Industry: Drug Manufacturers - Major Quick infos Headquarters: Paris, France Trade prices Volume: 2.0M Market Cap: 127.39B Prev closed: Open: 52.31 High: 52.79 Low: 52.19 52 week low: 45.17 52 week high: 54.26 Dividends: Next ER: February 3, 2023 Before Market Opens
About the Company Sanofi S.A. is a French multinational healthcare company headquartered in Paris, France. Originally, the corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo.
Earnings History Date EPS / Forecast Revenue / Forecast April 27, 2023 February 3, 2023 1.71 / 0.9210.72B / 12.2BOctober 28, 2022 1.43 / 1.3113.07B / 12.98BBeat! July 28, 2022 0.8785 / 0.83910.27B / 10.12BBeat! April 28, 2022 1.01 / 0.960510.57B / 10.46BBeat! view more
Historical Data Date Price Open High Low Vol Change ER Aug 16, 2022 44.81 43.65 44.88
43.44
3.76M 2.24% Aug 15, 2022 43.83 43.69 44.10
43.13
3.07M -1.22% Aug 12, 2022 44.37 43.97 44.59
43.73
4.73M 2.19% Aug 11, 2022 43.42 42.02 44.27
41.91
21.75M -3.94% Aug 10, 2022 45.20 46.86 46.93
43.20
9.88M -7.11% Aug 9, 2022 48.66 48.79 48.95
48.60
2.73M -0.86% Aug 8, 2022 49.08 49.16 49.54
48.99
1.41M -1.27% Aug 5, 2022 49.71 49.19 49.78
49.17
859.91K 1.08% Aug 4, 2022 49.18 49.45 49.52
49.01
1.04M 0.70% Aug 3, 2022 48.84 49.48 49.54
48.83
1.79M 0.08% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:August 20, 2004 Employees:95,442 News
Sanofi (SNY) Dips More Than Broader Markets: What You Should Know finance.yahoo.com Mar 23, 2023 6:00 pm Sanofi stock rises as Dupixent shows benefit in lung disease smokers, meets phase 3 goals seekingalpha.com Mar 23, 2023 5:31 pm UPDATE 3-Sanofi to cut US price of its most-prescribed insulin by 78% finance.yahoo.com Mar 23, 2023 4:45 pm
Press Release: Sanofi cuts U.S. list price of Lantus®, its most-prescribed insulin, by 78% and caps out-of-pocket Lantus costs at $35 for all patients with commercial insurance finance.yahoo.com Mar 23, 2023 4:06 pm
Pfizer Agrees to Buy Seagen for $43 Billion finance.yahoo.com Mar 23, 2023 3:06 pm
Why Shares of Regeneron Are Rising Thursday finance.yahoo.com Mar 23, 2023 12:08 pm UPDATE 4-U.S. FDA approves Sanofi's bleeding disorder therapy finance.yahoo.com Mar 23, 2023 11:56 am
Provention Bio Stock Soars on $2.9 Billion Acquisition by Sanofi finance.yahoo.com Mar 23, 2023 11:38 am
Regeneron (REGN) Q4 Earnings & Sales Beat, Eylea Sales Decline finance.yahoo.com Mar 23, 2023 11:35 am
ALTUVIIIO approved by the U.S. FDA: this positive event triggers impairment reversal, positively impacting 2022 IFRS net income; no change on business net income (non-IFRS) finance.yahoo.com Mar 23, 2023 11:16 am
Novo Nordisk (NVO) Follows Lilly, to Cut Insulin Prices by 75% finance.yahoo.com Mar 23, 2023 10:39 am
Sanofi becomes latest to cut insulin prices, joins Novo Nordisk, Eli Lilly finance.yahoo.com Mar 23, 2023 10:15 am
Why Regeneron Pharmaceuticals And Sanofi Shares Are Trading Higher Today finance.yahoo.com Mar 23, 2023 9:20 am Pfizer Officially Nabs Seagen For $43 Billion; Provention Soars On Sanofi Deal finance.yahoo.com Mar 23, 2023 9:17 am Sanofi, AstraZeneca Tee Up A Rival To Pfizer In The Multibillion-Dollar RSV Race finance.yahoo.com Mar 23, 2023 8:15 am
Sanofi, Regenerons Drug Succeeds in High-Stakes Lung Trial finance.yahoo.com Mar 23, 2023 8:14 am
Sanofi Expects Moderate 2023 Profit Growth On Dupixent Demand, But Dampened By Aubagio Generics Competition finance.yahoo.com Mar 23, 2023 6:39 am Drug developer QurAlis raises $88 mln in Sanofi-backed funding round finance.yahoo.com Mar 23, 2023 4:30 am
Sanofi rises as analysts eye results from smoker's lung drug trial finance.yahoo.com Mar 23, 2023 4:12 am Sanofi to buy Provention Bio in deal worth $2.9 billion finance.yahoo.com Mar 23, 2023 2:49 am SNY Dividends Ex-Dividend Amount Announced Date Record Date Payment Date May 30, 2023 1.3773019 Jun 23, 2023 May 26, 2022 0.1766908 Jun 27, 2022 May 4, 2022 1.26013 May 31, 2022 May 3, 2021 1.3676566 May 26, 2021 Apr 30, 2020 1.1735676 May 26, 2020 view more
Key Persons CEO : Paul Hudson (1 Sep 2019–) Talk about Sanofi below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Very few careers can offer you the freedom, flexibility, and income that day trading does. As a day trader, you can live and work anywhere in the world. You can decide when to work and when not to work. You only answer to yourself. That is the life of the successful day trader. Many people aspire to it, but very few succeed.
A Beginner's Guide to Trading Tools and Tactics, Money Management, Discipline and Trading Psychology